Predicting response to biologics in inflammatory bowel disease

Not Applicable

Recruiting

• Conditions: Inflammatory bowel disease; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12613001292763
• Lead Sponsor: niversity of Otago Christchurch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Patients with inflammatory bowel disease as determined by standard clinical and endoscopic criteria

Exclusion Criteria

Unwilling to provide informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response to biologic as determined by disease activity index is correlated with biologic trough concentration.[During treatment, at least 12 weeks after commencing treatment, compared to baseline.]

Secondary Outcome Measures

Name	Time	Method
Response to biologic as determined by disease activity index, correlated with anti-drug antibody concentration[At least 12 weeks after commencing treatment, compared to baseline]